 Cubist Systematic Strategies LLC purchased a new stake in shares of PDL BioPharma Inc NASDAQ:PDLI in the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 35,935 shares of the biotechnology companys stock, valued at approximately 117,000. A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes ... 